Showing results (1001-1010 of 2,037) with videos related to

Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|October 1, 1994
[Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders]H B Saur, P Bartenstein, O Schober, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1994
[Intra- and extrahepatic shunts in liver cirrhosis--evaluation by means of combined invasive nuclear medicine methods]J Kropp, B Schneider, K Lackner, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1994
[Scintigraphy using 131I in oxyphilic carcinomas of the thyroid gland]A Hamann, K F Gratz, B Soudah, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1994
[Simultaneous measumrement of the renal excretion of 131I-hippuran and 99mTc-MAG3]H J Schroth, J Bialy, M Bühler, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1994
[Anaphylactic shock after repeated injection of 99mTc-labeled CEA antibody]L Rettenbacher, G Galvan
Nuklearmedizin. Nuclear Medicine|October 13, 2021
[Therapy concepts for thyroid carcinoma]Friederike Eilsberger, Michael C Kreissl, Markus Luster, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
Nuklearmedizin. Nuclear Medicine|April 14, 2022
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/mlThabo Lengana, Ismaheel Lawal, Charl Janse Van Rensburg, et al.
Nuklearmedizin. Nuclear Medicine|September 11, 2023
Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLCKatharina Deininger, Joel Niclas Raacke, Elham Yousefzadeh-Nowshahr, et al.
Pageof 204